Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
Clinical trial NCT01475253 · TERMINATED
Trial details
- NCT number
- NCT01475253
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-12-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.